prognostic factors Archives - ACR Meeting Abstracts

Abstract Number: 0865 • ACR Convergence 2026
The endothelial activation and stress index (EASIX) predicts Clinical Progression to Antiphospholipid Syndrome in Antiphospholipid Antibody Carriers
Rafael Galvez¹, Rodrigo Cantera², Maria Oviedo³, Maria abando³, Hector Cruz³, Raquel García³, Marina Herrero³, Jose Antonio Flores³, Irene Gorostidi³, Ariadna Garcia⁴, Ligia Gabrie⁵, Lucrecia Yanez³, Marcos Lopez⁶, Juan Jose Dominguez³, Luisa Gonzalez³, Belen Gonzalez³, Jose Luis Hernandez⁷ and Victor Manuel¹ Affiliations: ¹Department of Rheumatology, Hospital Universitario Marqués de Valdecilla; Immunopathology Group, IDIVAL. Department of Medicine and Psychiatry, University of Cantabria, Santander, Spain, Santander, Spain, ²Division of Hematology. Hospital Universitario de Navarra, Navarra, Spain, ³Division of Hematology. Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain, Santander, Spain, ⁴Division of Hematology. Hospital Universitario Araba, Vitoria, Spain, Santander, Spain, ⁵Division of Rheumatology. Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain, Santander, Spain, ⁶Marques de Valdecilla University Hospital-IDIVAL, Santander, Spain, ⁷Hospital Universitario Marqués de Valdecilla-IDIVAL, Immunopathology Group, Department of Internal Medicine and Psychiatry, University of Cantabria, Santander, Spain, Santander, Spain
Background/Purpose: Endothelial dysfunction is a key mechanism in antiphospholipid syndrome (APS). However, biomarkers able to predict clinical progression in asymptomatic antiphospholipid antibody (aPL) carriers are…
Abstract Number: 1917 • ACR Convergence 2026
Enhancing SLE Clinical Trial Efficiency With Prognostic Score Covariate Adjustment
Roland Brown¹, Eric Morand², Wenting Cheng¹, Jessica Kong¹, Effie Pournara³ and Feng Gao¹ Affiliations: ¹Biogen, Cambridge, MA, USA, Cambridge, ²Centre for Inflammatory Disease, Monash University, Melbourne, Victoria, Australia, Melbourne, Victoria, Australia, ³Biogen, Baar, Zug, Switzerland, Zürich, Switzerland
Background/Purpose: Adjusting for prognostic covariates or prognostic scores (PS) that capture baseline predictors of disease progression is a method supported by the regulatory agencies to…
Abstract Number: 0004 • ACR Convergence 2026
Baseline and early longitudinal serum biomarkers in Polymyalgia Rheumatica: kinetics and associations with clinical course
Pablo Muñoz-Martínez¹, Elena Grau García², Iago Alcántara Álvarez³, Belén Villanueva Mañes³, Miguel Simeó Vinaixa³, Andres Perez Hurtado³, patricia anton Enguidanos³, Belen diaz Mora³, Alba Maria Torrat Noves⁴, Daniel Ramos Castro³ and Jose Andres Roman Ivorra⁵ Affiliations: ¹1.Hospital Universitario y Politécnico La Fe; 2.Doctoral School Catholic University of Valencia San Vicente Mártir, Sagunto, Comunidad Valenciana, Spain, ²HUP La Fe, Valencia, Spain, ³Rheumatology Department. HUP La Fe, Valencia, Spain, ⁴1.Rheumatology Department. HUP La Fe; 2.Doctoral School. Catholic University of Valencia San Vicente Mártir, Valencia, Spain, ⁵Hospital Universitari i Politècnic La Fe, Valencia, Spain
Background/Purpose: Polymyalgia rheumatica (PMR) is characterized by systemic inflammation and rapid response to glucocorticoids (GC), but its biological heterogeneity and molecular effects of early treatment…
Abstract Number: 0894 • ACR Convergence 2026
Risk Factors For Progression Of SI joint Structural Lesions On MRI In Early Axial SpA: 2-year Results From The SPondyloArthritis Caught Early Cohort
Haluk Cinakli¹, Liese de Bruin², Gizem Ayan³, Ana Bento da Silva², Manouk de Hooge⁴, Miranda van Lunteren², Monique Reijnierse⁵, Marleen Van de Sande⁶, Inger Jorid Berg⁷, Roberta Ramonda⁸, Sofia Exarchou⁹, Floris van Gaalen¹⁰ and Sofia Ramiro¹¹ Affiliations: ¹Manisa City Hospital, Manisa, Manisa, Turkey, ²Leiden University Medical Center, Leiden, Netherlands, ³Division of Rheumatology, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; Hacettepe University Vasculitis Research Center (HUVAC), Ankara, Turkey, Ankara, Turkey, ⁴Ghent University Hospital & Leiden University Medical Center, Leiden, Netherlands, ⁵Leiden University Medical Center, Department of Radiology, Leiden, Netherlands, ⁶University of Amsterdam, Amsterdam, Netherlands, ⁷Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Nepal, ⁸Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Italy, ⁹Lund University, Škarp, Sweden, ¹⁰Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ¹¹Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands and Zuyderland Medical Center, Heerlen, Netherlands
Background/Purpose: Structural lesions of the SI joints (SIJ) may be present in early axial SpA (axSpA), but data on risk factors for progression of such…
Abstract Number: 2129 • ACR Convergence 2026
A deep learning model predicting the survival of Anti-neutrophil cytoplasmic antibody -associated vasculitis
Xixi Shang Affiliations: 北京协和医院, Beijing, China (People's Republic)
Background/Purpose: Objective: To comprehensively identify prognostic risk factors and predict survival outcomes in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) utilizing deep learning techniques.Methods: Methods: We analyzed…
Abstract Number: 0181 • ACR Convergence 2026
Neurological involvement and elevated erythrocyte sedimentation rate may predict relapse in the Takayasu Arteritis Early Inception Cohort
Fatma Alibaz-Oner¹, Sema Kaymaz-Tahra², Aysegul Avcu³, Mustafa Ekici⁴, Buğu Bulat⁵, Fatih Albayrak⁶, HASAN KOCAAYAN⁷, Dilara Bulut-Gökten⁸, Pinar Akyuz Dagli⁹, Huseyin T E Ozer¹⁰, Burak Okyar¹¹, Tuba Demirci-Yildirim¹², Gökçe Kenar Artın¹³, Emel Oguz Kokoglu¹⁴, Ertuğrul Çağrı Bölek¹⁵, Hatice Vildan Polat¹⁶, Ragip Cetinkaya¹⁶, Simay Erdal Sayin¹⁶, Banu Ucmaklioglu¹⁶, Cemal Bes¹⁷, Nilufer Alpay-Kanitez¹⁸, AYTEN YAZICI¹⁹, Ayse Cefle²⁰, Nursen Duzgun²¹, Ediz Dalkilic²², Sule Yavuz²³, Lutfi Akyol²⁴, Melike Kalfa²⁵, Timucin Kasifoglu²⁶, Gözde Yıldırım Çetin¹¹, Mehmet Akif Ozturk²⁷, Soner Senel¹⁴, Fatos Onen¹², Suleyman Ozbek¹⁰, Ahmet Omma⁹, Ridvan Mercan⁸, Servet Akar²⁸, Orhan Zengin²⁹, Omer Karadag⁴ and Haner Direskeneli¹ Affiliations: ¹Division of Rheumatology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Istanbul, Turkey, ²Bahcesehir University Faculty of Medicine, Istanbul, Turkey, ³Marmara University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, ⁴Hacettepe University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ⁵Division of Rheumatology, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; Hacettepe University Vasculitis Research Center (HUVAC), Ankara, Turkey, Ankara, Turkey, ⁶Gaziantep University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Gaziantep, Turkey, ⁷Izmir Katip Celebi University School of Medicine, Department of Internal Medicine, Division of Rheumatology Izmir Ataturk Education and Reseach Hospital, Izmir, Izmir, Turkey, ⁸Tekirdağ Namık Kemal University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Tekirdağ, Turkey, ⁹Ankara City Hospital, Rheumatology Clinic, Ankara, Turkey, ¹⁰Çukurova University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Adana, Turkey, ¹¹Kahramanmaraş Sütçü İmam University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Kahramanmaraş, Turkey, ¹²Dokuz Eylül University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey, ¹³Dokuz Eylul University School of Medicine, Izmir, Izmir, Turkey, ¹⁴Erciyes University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Kayseri, Turkey, ¹⁵Division of Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine, Ankara, Turkey, Ankara, Turkey, ¹⁶Marmara University School of Medicine, Istanbul, Turkey, ¹⁷Division of Rheumatology, Department of Internal Medicine, Başaksehir Cam ve Sakura City Hospital, Istanbul, Istanbul, Turkey, ¹⁸Division of Rheumatology, Department of Internal Medicine, School of Medicine, Koc University, Istanbul, Istanbul, Turkey, ¹⁹Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kocaeli University, Istanbul, Turkey, ²⁰Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kocaeli University, Kocaeli, Turkey, ²¹Ankara University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ²²Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Uludag University, Bursa, Turkey, ²³Istanbul Bilim University School of Medicine, Department of Internal Medicine, Rheumatology Clinic, Istanbul, ²⁴Ondokuz Mayıs University School of Medicine, Internal Medicine, Division of Rheumatology,, Samsun, Turkey, ²⁵Muğla Sıtkı Koçman University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Muğla, ²⁶Osmangazi Uni., Eskisehir, Turkey, ²⁷Gazi University School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ²⁸Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ²⁹Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
Background/Purpose: Takayasu arteritis (TAK) is a rare large-vessel vasculitis for which long-term prognostic data remain limited and are mostly derived from retrospective studies. This study…
Abstract Number: 0954 • ACR Convergence 2026
Serial Quantitative Changes in Anti-Scl-70 Autoantibodies Are Associated with Lung Function Decline in Systemic Sclerosis
Eric Robbins¹, Julio Huapaya¹, Xin Tian², Shijinqiu Gao³, Harshkumar Patel⁴, Peter Burbelo⁵, Tracy Frech⁶, Jessica Gordon⁷, Maureen Mayes⁸, Lorinda Chung⁹, Ankoor Shah¹⁰, Flavia Castelino¹¹, Brian Skaug¹², Peter A. Merkel¹³, Nora Sandorfi¹³, Faye Hant¹⁴, Ashima Makol¹⁵, Carrie Richardson¹⁶, Laura Hummers¹⁷, Dinesh Khanna¹⁸, Zsuzsanna McMahan¹⁹, Jerry Molitor²⁰, Melissa Griffith²¹, Duncan Moore²², Kimberly Lakin⁷, Elizabeth Volkmann²³, Ami Shah²⁴, Yiming Luo²⁵, Carleigh Zahn²⁶, Sonali J Bracken²⁷, Julie Paik²⁸, Andreea Bujor²⁹, Erica Mulcaire-Jones²⁶, Dorota Lebiedz-Odrobina³⁰, Neha Gupta⁴, Ching (Katharine) Chung³¹, Luke Evnin³², Elana Bernstein²⁵, Monica Harding³³, John VanBuren³³, Shervin Assassi³⁴, Anthony Suffredini⁴ and Virginia Steen³⁵ Affiliations: ¹Critical Care Medicine and Pulmonary Branch; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD, ²Office of Biostatistics Research; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD, ³Office of Biostatistics Research; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, ⁴Critical Care Medicine and Pulmonary Branch; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, ⁵National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, ⁶Vanderbilt Health, Nashville, TN, ⁷Hospital for Special Surgery, New York, NY, ⁸UT Health Houston Division of Rheumatology, Houston, TX, ⁹Stanford University School of Medicine, Stanford, CA, ¹⁰Duke University, Durham, NC, ¹¹Massachusetts General Hospital, Boston, MA, ¹²UTHealth Houston Division of Rheumatology, Houston, TX, ¹³University of Pennsylvania, Philadelphia, PA, ¹⁴Medical University of South Carolina, Charleston, SC, ¹⁵Mayo Clinic, Rochester, MN, Rochester, MN, ¹⁶Northwestern University, Chicago, IL, ¹⁷Johns Hopkins Rheumatology, Baltimore, MD, ¹⁸Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, Ann Arbor, MI, ¹⁹UT Health Houston, Houston, TX, ²⁰University of Minnesota, Minneapolis, MN, ²¹University of Colorado, Aurora, CO, ²²Northwestern Memorial Hospital, Wilmette, IL, ²³University of California, Los Angeles, Los Angeles, CA, ²⁴Johns Hopkins Rheumatology, Ellicott City, MD, ²⁵Columbia University, New York, NY, ²⁶University of Michigan, Ann Arbor, MI, ²⁷Duke University Medical Center, Durham, NC, USA, Durham, NC, ²⁸Johns Hopkins University, Baltimore, MD, ²⁹Boston University, Boston, MA, ³⁰University of Utah, Cottonwood Heights, UT, ³¹National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ³²Scleroderma Research Foundation, Brisbane, CA, ³³Division of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, ³⁴Division of Rheumatology, UTHealth Houston, Houston, TX, ³⁵Georgetown University School of Medicine, Washington, DC
Background/Purpose: Anti-topoisomerase I autoantibodies (anti-Scl-70) are associated with systemic sclerosis-associated interstitial lung disease (SSc-ILD), but prior prognostic studies have largely focused on cross-sectional autoantibody status.…
Abstract Number: 2172 • ACR Convergence 2026
Forced Vital Capacity Trajectories During the Treatment-Naïve Period in Systemic Sclerosis: A 20-Year Ambispective Cohort Study
HEE WON CHO¹, YunHee Choi², Jun Won Park³, Jin Kyun Park⁴ and Eun Bong Lee⁵ Affiliations: ¹Seoul National University, Jongno District, Seoul, Republic of Korea, ²Seoul National University, Seoul, Republic of Korea, ³Seoul National University Hospital, Seoul, South Korea, ⁴Seoul National University College of Medicine, Seoul, Republic of Korea, ⁵Seoul National University Hospital, Seoul, Republic of Korea
Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease in which pulmonary involvement is a major cause of mortality. Despite its clinical importance, the natural…
Abstract Number: 0194 • ACR Convergence 2026
Baseline ‘aggregate index of systemic inflammation’ reflects current high activity and predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Juyoung Yoo¹, Jihye Chung² and Sang-Won Lee³ Affiliations: ¹Yonseidael Clinic, Seoul, Republic of Korea, ²Severance hospital, Seoul, Republic of Korea, ³Yonsei University College of Medicine, Seoul, South Korea
Background/Purpose: The aggregate index of systemic inflammation (AISI) was recently introduced as a prognostic index in various inflammatory diseases. This study investigated the clinical utility…
Abstract Number: 1019 • ACR Convergence 2026
Genetic predisposition to Systemic Lupus Erythematosus increases Decoy receptor 3 levels, which associate with disease severity and progression
Sarah Reid, Ioanna Giannakou, Joachim Burman, Lars Rönnblom, Maija-Leena Eloranta and Dag Leonard Affiliations: Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a heterogeneous autoimmune disease characterized by loss of tolerance to self-antigens, immune complex formation and activation of the interferon…
Abstract Number: 2175 • ACR Convergence 2026
Initial Presentation Of Systemic Sclerosis (SSc) Defines Clinically Meaningful SSc Phenotypes
Liu Liu¹, Sophie Krijger¹, Katie van der Wouden¹, Lianne Kwant¹, Yvo Santema¹, Tom Huizinga¹, Jacopo Ciaffi², Anne Schouffoer³ and Jeska de Vries¹ Affiliations: ¹Leiden University Medical Center, Leiden, Netherlands, ²IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, ³Hagaziekenhuis, the Hague, Netherlands
Background/Purpose: To enhance early recognition of systemic sclerosis (SSc), the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria were developed to identify patients with Raynaud…
Abstract Number: 0220 • ACR Convergence 2026
High-Intensity Immunosuppression with Autologous Stem Cell Transplantation Versus Modern Standard Care in Poor-Prognosis Diffuse Cutaneous Systemic Sclerosis: A Propensity-Matched Study
Lucas Khellaf¹, Rémi Khellaf², Pierre Pinson³, Yannick Allanore⁴, Zahir Amoura⁵, Jerome Avouac⁶, Tiphaine Goulenok⁷, Bertrand Dunogue⁸, Anuxcy Kanagaratnam⁹, Sebastien riviere¹⁰, Guillaume Buissone¹¹, Robin Dhote¹², Jean-Emmanuel kahn¹³, Olivier Lidove¹⁴, MEKINIAN Arsene¹⁵, Didier Bouscary¹⁶, Luc Mouthon⁸ and Benjamin Chaigne⁸ Affiliations: ¹Cochin university Hospital, Paris, France, ²INRIA, PreMeDICaL Team, Montpellier University, Montpellier, France;, Paris, France, ³Clinical Research Unit, Cochin Hospital, AP-HP, University Paris Cité, Paris;, Paris, France, ⁴Université Paris Cité, Paris, France, ⁵Service de médecine interne 2, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique, Groupement hospitalier Pitié-Salpêtrière, Institut E3M, AP-HP,, Paris, France, ⁶National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, AP-HP, Paris, France, Paris (75014), France, ⁷Department of Internal Medicine, Bichat-Claude Bernard Hospital, AP-HP, Paris, France, ⁸Internal Medicine Department, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, Cochin Hospital, APHP, Paris Cité University, Paris, France, ⁹Internal medicine department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;, paris, ¹⁰Internal medicine department, AP-HP Sant-Antoine Hospital, Paris;, paris, France, ¹¹Internal medicine department, AP-HP Antoine Béclère Hospital, Paris;, Paris, France, ¹²Internal medicine department, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;, Paris, France, ¹³CHU Ambroise Paré, Suresnes Cedex, ¹⁴Internal medicine and Rheumatology department, Diaconesses-Croix Saint Simon Hospital Group, Paris, France., Paris, France, ¹⁵Internal Medicine Department, Saint Antoine Hospital, APHP, Sorbonne University, Paris, France, ¹⁶Hematology department, Cochin Hospital, AP-HP, Paris., Paris, France
Background/Purpose: The 2023 EULAR update recommends high-intensity immunosuppression followed by autologous hematopoietic stem-cell transplantation (HI-IS/HSCT) for selected patients with poor-prognosis early diffuse cutaneous systemic sclerosis…
Abstract Number: 1134 • ACR Convergence 2026
High Visual Burden and Distinct Cranial Phenotype in an Irish Giant Cell Arteritis Cohort
Danielle Molloy¹, Colm Kirby², Sharon Cowley³, Patricia Harkins⁴, Richard Conway⁵, Grainne Murphy⁶ and David Kane⁷ Affiliations: ¹Tallaght University Hospital, Tallaght, Dublin, Ireland, ²Tallaght University Hospital, Dublin, Ireland, ³Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, ⁴Trinity College Dublin, Dublin 8, Dublin, Ireland, ⁵Trinity College Dublin, Dublin, Ireland, ⁶Cork University Hospital, Cork, Ireland, ⁷Tallaght University Hospital & Trinity College Dublin, D24, Dublin, Ireland
Background/Purpose: Giant cell arteritis (GCA) demonstrates heterogenous clinical phenotypes with variable cranial, systemic and visual involvement. Visual loss remains the most feared complication of GCA…
Abstract Number: 2176 • ACR Convergence 2026
Neutrophil-to-Lymphocyte Ratio Is Associated With Progression From VEDOSS to Definite Systemic Sclerosis
Francesco Bonomi¹, Cristiano Barbetta², Martina Iacubino³, Veronica De Silvestri⁴, Silvia Peretti⁵, Lorenzo Beretta⁶, Chiara Bellocchi⁷ and Silvia Bellando Randone⁸ Affiliations: ¹Azienda Ospedaliera Universitaria Careggi, Florence, Italy, ²Department of Experimental and Clinical Medicine, Division of Rheumatology, Florence, Italy, ³Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, ⁴University Hospital Careggi, Florence, Italy, ⁵Department of Internal Medicine, Careggi University Hospital, Florence, Italy, ⁶Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano, Milan, Milan, Italy, ⁷4. Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy, ⁸Department of Experimental and Clinical Medicine, University of Florence, Rheumatology Division, Scleroderma Unit. AOU Careggi, Florence, Italy, Florence, Italy

Background/Purpose: Risk stratification in VEDOSS remains challenging, as only a proportion of patientsprogress to definite systemic sclerosis (SSc) during follow-up. Current predictors are mainlyclinical, serological…
Abstract Number: 0234 • ACR Convergence 2026
Evidence-based predictors of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPFstudy (CP number 148)
Corrado Campochiaro¹, Donato Tiano², Denis Morgin³, Daniele Celada⁴, Simone Barbieri⁴, Claudia Iannone¹, Giacomo De Luca¹, Patricia Carreira⁵, Jeska de Vries⁶, Gabor Kumanovics⁷, Radim Bečvář⁸, Oliver Distler⁹, Alexandra Balbir-Gurman¹⁰, Enrico Selvi¹¹, Alberto Cauli¹², Simona Rednic¹³, Francesco Del Galdo¹⁴, Marco Di Battista¹⁵, Jelena Colic¹⁶, Carlo Tacchetti⁴, Masataka Kuwana¹⁷, Marie-Elise Truchetet¹⁸, Marco Matucci-Cerinic¹⁹, Michele Iudici³ and Yannick Allanore²⁰ Affiliations: ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy, ²S-RACE (San-Raffaele Ai CEnter), Vita-Salute San Raffaele University, Milan, Italy, ³University of Geneva, Rheumatology, Geneve, Switzerland, ⁴S-RACE (San-Raffaele Ai CEnter), University Vita-Salute San Raffaele, Milan, Italy, ⁵Hospital Universitario 12 de Octubre, Madrid, Spain, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷Department of Rheumatology, Immunology and Musculoskeletal Rehabilitation, Medical School, University of Pécs, Hungary, Pécs, Baranya, Hungary, ⁸Institute of Rheumatology, Prague, Czechia; First Faculty of Medicine, Charles University, Prague, Czechia, Prague, Czech Republic, ⁹Department of Rheumatology, University Hospital, Zurich, Switzerland, Zurich, Switzerland, ¹⁰Rheumatology Institute, Rambam Health Care Campus and The Rappaport Faculty of |Medicine, Technion, Haifa, Israel, ¹¹Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Rheumatology, Siena, Italy, ¹²AOU and University Hospital Of Cagliari, Rheumatology, Cagliari, Cagliari, Italy, ¹³University of Medicine and Pharmay, Cluj-Napoca, Rheumatology, Cluj-Napoca, Romania, ¹⁴University of Leeds, Leeds, United Kingdom, ¹⁵University of Pisa, Rheumatology, Pisa, Italy, ¹⁶Rheumatology, University of Belgrade Faculty of Medicine, Beograd, Serbia, Rheumatology, University of Belgrade Faculty of Medicine, Beograd, Serbia, Serbia, ¹⁷Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ¹⁸Bordeaux University Hospital, Bordeaux, France, ¹⁹University San Raffaele Milano, Milano, Milan, Italy, ²⁰Rheumatology Department, Cochin Hospital, Université Paris Cité, Paris, France
Background/Purpose: Interstitial lung disease(ILD) is the leading cause of mortality in systemic sclerosis(SSc). Identifying patients at risk of progression remains a major clinical challenge.Methods: SSc-ILD…

Abstracts tagged "prognostic factors"